Home Table of Contents

§ 12-6A-01. Definitions

West's Annotated Code of MarylandHealth OccupationsEffective: October 1, 2023

West's Annotated Code of Maryland
Health Occupations (Refs & Annos)
Title 12. Pharmacists and Pharmacies (Refs & Annos)
Subtitle 6a. Therapy Management Contracts (Refs & Annos)
Effective: October 1, 2023
MD Code, Health Occupations, § 12-6A-01
§ 12-6A-01. Definitions
Currentness
In general
(a) In this subtitle the following words have the meanings indicated.
Authorized prescriber
(b) “Authorized prescriber” means a licensed physician, licensed podiatrist, or certified advanced practice nurse with prescriptive authority under § 8-508 of this article.
Group model health maintenance organization
(c) “Group model health maintenance organization” has the meaning stated in § 19-713.6 of the Health--General Article.
Health maintenance organization
(d) “Health maintenance organization” has the meaning stated in § 19-701(g) of the Health--General Article.
Institutional facility
(e)(1) “Institutional facility” means a facility other than a nursing home whose primary purpose is to provide a physical environment for patients to obtain inpatient or emergency care.
(2) “Institutional facility” does not include an urgent care facility that is not part of a facility.
Prescriber-pharmacist agreement
(f) “Prescriber-pharmacist agreement” means an agreement between an authorized prescriber and a licensed pharmacist that is disease-state specific and specifies the protocols that may be used.
Protocol
(g) “Protocol” means a course of treatment predetermined by the authorized prescriber and licensed pharmacist according to generally accepted medical practice for the proper completion of a particular therapeutic or diagnostic intervention.
Therapy management contract
(h) “Therapy management contract” means a voluntary arrangement that is:
(1) Disease-state specific;
(2) Agreed on by:
(i) One licensed pharmacist and the licensed pharmacist's designated alternate licensed pharmacists;
(ii) One authorized prescriber and alternate designated authorized prescribers involved directly in patient care; and
(iii) One patient receiving care from an authorized prescriber and a licensed pharmacist pursuant to a prescriber-pharmacist agreement and protocol under this subtitle; and
(3) Related to treatment using drug therapy, laboratory tests, or medical devices, under defined conditions or limitations for the purpose of improving patient outcomes.

Credits

Added by Acts 2002, c. 249, § 1, eff. Oct. 1, 2002. Amended by Acts 2009, c. 314, § 1, eff. Oct. 1, 2009; Acts 2009, c. 315, § 1, eff. Oct. 1, 2009; Acts 2012, c. 658, § 1, eff. July 1, 2012; Acts 2015, c. 269, § 1, eff. Oct. 1, 2015; Acts 2023, c. 399, § 1, eff. Oct. 1, 2023.
MD Code, Health Occupations, § 12-6A-01, MD HEALTH OCCUP § 12-6A-01
Current through legislation effective through April 9, 2023, from the 2024 Regular Session of the General Assembly. Some statute sections may be more current, see credits for details.
End of Document